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Long-term trends in Indigenous deaths from chronic diseases
in the Northern Territory: a foot on the brake,
a foot on the accelerator
David P Thomas, John R Condon, Ian P Anderson, Shu Q Li, Stephen Halpin, Joan Cunningham and Steven L Guthridge

T

here are too many funerals; too many
Aboriginal and Torres Strait Islander
men and women die too early. New
research is not needed to restate this ignominy, but Indigenous people, policymakers
and all other Australians need to know if
this problem is getting better or worse. This
is not always possible because of limitations
in data quality and availability.
Recent research has shown long-term
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Research
because
appropriate datasets for both deaths
and population estimates from 1967 to
2000 have recently been developed; trends
in specific causes of death can only be
examined from 1977 because a high proportion were coded with an unknown or nonspecific cause in earlier years. These datasets
have been used to show statistically significant reductions in all-cause mortality, especially in those aged under 5 years, and in
deaths from both communicable diseases
and injuries in those aged 5 years and over.
In spite of these improvements, the ratio
of NT Indigenous to total Australian mortality rates increased, except for a decrease in
children aged under 5 years.1,2 Further, NT
Indigenous non-communicable disease
mortality did not decrease from 1977 to
2000.2 Were there differences between diseases in this large category? Mixed changes
in cancer mortality, including increases in
smoking-related cancer deaths, have already
been reported.3 In this article, we report
mortality of the other non-communicable
diseases causing the most NT Indigenous
deaths4 — ischaemic heart disease (IHD),
chronic obstructive pulmonary disease
(COPD), cerebrovascular disease (CVD),
diabetes mellitus (DM), renal failure (RF)
and rheumatic heart disease (RHD).
METHODS
We used the previously described long-term
time series of death and population data for
Indigenous people in the NT, extended to
include 2001.1 Comparison death and population data for the total Australian popula-

ABSTRACT
Objective: To examine trends in Northern Territory Indigenous mortality from chronic
diseases other than cancer.
Design: A comparison of trends in rates of mortality from six chronic diseases
(ischaemic heart disease [IHD], chronic obstructive pulmonary disease [COPD],
cerebrovascular disease [CVD], diabetes mellitus [DM], renal failure [RF] and rheumatic
heart disease [RHD]) in the NT Indigenous population with those of the total Australian
population.
Participants: NT Indigenous and total Australian populations, 1977–2001.
Main outcome measures: Estimated average annual change in chronic disease
mortality rates and in mortality rate ratios.
Results: Death rates from IHD and DM among NT Indigenous peoples increased
between 1977 and 2001, but this increase slowed after 1990. Death rates from COPD
rose before 1990, but fell thereafter. There were non-significant declines in death rates
from CVD and RHD. Mortality rates from RF rose in those aged ⭓ 50 years. The ratios
of mortality rates for NT Indigenous to total Australian populations from these chronic
diseases increased throughout the period.
Conclusions: Mortality rates from IHD and DM in the NT Indigenous population
have been increasing since 1977, but there is evidence of a slower rise (or even a fall)
in death rates in the 1990s. These early small changes give reason to hope that some
improvements (possibly in medical care) have been putting the brakes on chronic
disease mortality among Aboriginal and Torres Strait Islander peoples.
MJA 2006; 185: 145–149

tion were purchased from the Australian
Bureau of Statistics (ABS).
The dataset included deaths coded
according to the revision of the World
Health Organization’s International classification of diseases used at the time (ICD-8
[8th revision] for deaths registered 1977–
1978, ICD-9 for 1979–1996, and ICD-10
for 1997–2002). The ICD groupings for the
six diseases in NT government publications
were used.5 The comparability of deaths
coded according to ICD-10 and ICD-9 was
tested by means of an ABS sample of 34 780
Australian deaths coded according to both
methods. The comparability factor (ICD-10
deaths/ICD-9 deaths) ranged from 93.4% to
105.1% for five of the six diseases. The
much lower comparability factor of 68.8%
for chronic RHD was based on a much
smaller sample of deaths, and is of uncertain
reliability.
All analyses were of the recorded single
final underlying cause of death. Multiple
causes of death, only available since 1997,
MJA • Volume 185 Number 3 • 7 August 2006

were compared with the underlying cause
from 1997 to 2001.
Statistical analysis
The annual change in the NT Indigenous
mortality rate for each disease was estimated
by means of Poisson regression models. The
annual change in the ratio of the mortality
rate of the NT Indigenous population to that
of the total Australian population for each
disease was estimated by means of negative
binomial (rather than Poisson) regression
models, as these data were found to be overdispersed.
Models were built based on deaths from
each of the six chronic diseases as the
outcome variable, and the population for
each age and sex group for each year as the
exposure variable. Age was grouped in 5year categories. Models tested variables for
death year, sex, age, age squared (and a
dichotomous variable distinguishing NT
Indigenous deaths from total Australian
deaths in the ratio trend models), and inter145

R ES E A R C H

1 Estimated change in Northern Territory Indigenous mortality rates,
1977–2001*
Disease

Deaths

Per cent average
annual change (95% CI)

Ischaemic heart disease

918

+ 2.5 (1.6 to 3.5)

Chronic obstructive pulmonary disease

639

– 1.2 (– 2.2 to – 0.1)

Cerebrovascular disease

441

– 0.6 (– 1.9 to 0.6)

Diabetes mellitus

369

+ 6.4 (4.7 to 8.0)

Rheumatic heart disease

201

– 1.1 (– 3.0 to 0.8)

Renal failure

179

Age < 50 years†

– 6.5 (– 10.7 to – 2.0)

Age ⭓ 50 years

+ 3.3 (0.8 to 5.7)

Per cent total
change
+ 81.3
– 25
ns
+ 338
ns
– 79.8
+ 117.2

ns = Not statistically significant (P ⭓ 0.05).
* Estimated by Poisson regression models. † There were only 35 NT Indigenous deaths from renal failure
among those aged < 50 years from 1977 to 2001, so estimated average annual changes for this age group
should be interpreted with caution.
◆

2 Comparison of estimated annual change in Northern Territory Indigenous
mortality rates in 1977–1989 and 1990–2001*
Per cent average annual change (95% CI)
Disease

1977–1989

1990–2001

P‡

Ischaemic heart disease

+ 5.7 (2.7 to 8.8)

+1.1 (– 1.3 to 3.5)

< 0.05

Chronic obstructive
pulmonary disease

+ 3.5 (0.5 to 6.7)

– 5.7 (– 8.6 to – 2.6)

< 0.001

Cerebrovascular disease
Diabetes mellitus
Rheumatic heart disease

+ 0.3 (– 3.3 to 4.0)

– 1.3 (– 4.9 to 2.5)

0.5

+ 13.5 (7.2 to 20.2)

+3.2 (– 0.4 to 6.9)

< 0.01

+ 5.9 (0.4 to 11.7)

+1.6 (– 4.2 to 7.6)

0.3

Renal failure
Age < 50 years†

– 17.1 (– 27.4 to – 5.3)

– 10.5 (– 22.6 to 3.4)

0.4

Age ⭓ 50 years

+ 6.1 (– 1.3 to 14.0)

+ 6.0 (– 0.3 to 12.7)

1.0

* Estimated by Poisson regression models. † There were only 19 (1977–1989) and 16 (1990–2001) NT Indigenous
deaths from renal failure in those aged < 50 years in the two periods, so estimated average annual changes for
this age group should be interpreted with caution. ‡ Probability that the ratio of estimated annual change in
1977–1989 to change in 1990–2001 is not different from unity.
◆

action terms. Variables were deleted until
the most parsimonious model was found.
The estimates of change in the NT Indigenous mortality rate over the entire 25-year
period were calculated by raising the estimated annual change to the power of 24: the
number of years less one. Dummy variables
were added to each model to estimate the
annual change in rates and ratios in the first
half of the period (1977–1989) compared
with the second half (1990–2001), and the
effect of the change to ICD-10 on annual
change in the NT Indigenous death rates. A
sensitivity analysis of the effect of different
cutpoints on the comparison between the
first and second halves of the period was also
performed. The effect of possible coding
changes within circulatory diseases was
146

assessed by building models for all circulatory diseases combined, and for all circulatory diseases other than IHD, CVD and RHD.
To show trends graphically, mortality rates
were directly age-standardised and sexstandardised to the estimated NT Indigenous population on 30 June 2001, with the
year of death described by means of five 5year groups.
Stata software (version 8.2; StataCorp,
College Station, Tex, USA) was used for
statistical analyses. A more detailed technical report about methods and results is
available from the first author.
Ethical approval
The project was approved by the Human
Research Ethics Committee of the Menzies
MJA • Volume 185 Number 3 • 7 August 2006

School of Health Research and the NT
Department of Health and Community
Services, and by its Aboriginal Ethics Subcommittee.
RESULTS
In the 25 years from 1977 to 2001, the six
chronic diseases caused 2747 deaths among
NT Aboriginal and Torres Strait Islander
people, comprising 29.7% of NT Indigenous
deaths from 1977 to 2001.
Trends in NT Indigenous death rates
Over the 25 years, NT Indigenous mortality
rates increased significantly for IHD and DM
and fell significantly for COPD (Box 1).
There were decreases in CVD and RHD
mortality, but these were not statistically
significant. RF mortality trends were different for younger and older people. The mortality rate decreased for those aged less than
50 years, but increased for those aged 50
years and older; both trends were statistically significant, but there were only 35
deaths from RF among people aged under
50 years. The change in coding from ICD-9
to ICD-10 did not appear to significantly
modify, and thus explain, these mortality
trends.
There were differences in the mortality
trends for the six diseases between the
1980s and 1990s (Box 2). For COPD, mortality increased before 1990, but decreased
thereafter. Mortality from IHD and DM
increased throughout the period 1977–
2001, but the rate of increase slowed significantly after 1990. Similar differences
between the 1980s and 1990s were found in
CVD and RHD death rates, but these differences were not statistically significant. The
differences between the two periods were
not sensitive to changing the end date of the
first period.
A third of circulatory disease deaths (755/
2315) were from causes other than IHD,
CVD and RHD. There was no statistically
significant estimated annual change in all
deaths from circulatory disease, but the
annual 3.1% decline in deaths from circulatory diseases other than IHD, CVD and RHD
was statistically significant.
Trends in the comparison of NT
Indigenous and total Australian
death rates
Trends in both the NT Indigenous and total
Australian death rates are shown in Box 3.
From 1977 to 2001, the Australian direct
standardised rates fell for IHD, CVD, RHD
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Data limitations
Some misclassification of Indigenous status
in the datasets probably occurred, but this is
likely to be rare compared with other states
and territories. Misclassification of underlying cause of death is known to be a problem
in death registrations, including in the NT;
deaths from circulatory and respiratory diseases were overcounted and endocrine diseases (mainly DM) were undercounted in a
sample of 220 NT Indigenous deaths in
1992.7 However, no information is available
on whether this misclassification of diseases
was constant over the 25-year period.
The decline in the other circulatory disease deaths may indicate a trend in the
classification of circulatory diseases away
from these codes, perhaps even towards
IHD codes, and so may account for some of
the upward trend in IHD-coded deaths. We
are not convinced by the most extreme
explanation that would mean that NT
Indigenous chronic disease mortality was
only increasing for DM, with other death
rates constant or falling. But if true, this
would paint a less complex and even more
optimistic picture of NT Indigenous chronic
disease mortality. It seems more likely that
the true IHD and DM trends, with their
similar risk factors, were in parallel as
coded.
Our analysis of the underlying cause of
death, rather than multiple causes, does not
adequately count the association of RF with
many NT Indigenous deaths, because it is
often not subsequently listed as the underlying cause of death.
The regression models provide the most
accurate estimates of the 25-year trends as
they use data from the whole period, rather
than just comparing death rates at the start
and end of the period (which is very sensitive
to the endpoints chosen).6 However, the
models and their estimates rely on the
assumption that the annual percentage
change in death rates is constant. This was
most clearly untrue for COPD death rates,
which increased and then fell. Box 2 and Box
3 indicate where these estimated 25-year
trends do not appear to have been constant.

100
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DISCUSSION
It has previously been reported that NT
Indigenous death rates from all non-communicable diseases did not change between
1977 and 2000 (there was a 5% increase
which was not statistically significant).2
We have now shown that death rates from
IHD and DM increased in the NT Indigenous population between 1977 and 2001,
and that the gap between the NT Indigenous
death rates and total Australian death rates
is getting larger for six common chronic
diseases. This is consistent with the popular
perception that things have not improved
for Indigenous peoples and that Australia is
becoming less fair.
However, recent research on Indigenous
mortality trends has reported more optimistic news. Statistically significant Indigenous
mortality declines in the 1990s have been
reported in non-communicable diseases
(and circulatory diseases in particular) in
Western Australia, and communicable diseases in males in WA and South Australia.6
Indigenous infant mortality declined in NT,
WA and SA in the 1990s.6 Data are of
insufficient quality to determine mortality
trends in other states.6
Similarly, our comparisons between the
two halves of the 25-year period give reason
for hope. NT Indigenous death rates from all
six chronic diseases were increasing more
slowly (or even decreasing) in the 1990s
compared with the 1980s. If this trend
continues, we might see significant
improvements in NT Indigenous chronic
disease mortality when more data from the
current decade are available.
The magnitude of the IHD, COPD and
DM trends are all larger than the previously
reported all-cause mortality trends in NT
Indigenous people aged over 5 years. The

3 Northen Territory Indigenous
and total Australian death rates,
1977–2001*

Deaths per 100 000 population

Underlying cause versus multiple
causes of death
In most of the deaths where RF was listed as
one of the multiple causes of death in 1997–
2001 (79%), it was not listed as the underlying cause of death. In such cases, the underlying disease was most likely to be listed as
DM or IHD. This occurred less often in the
other five chronic diseases.

largest estimated trends (in DM deaths and
in COPD deaths in 1990–2001) were even
greater than the reported fall in mortality in
those aged under 5 years.2

19

and COPD, remained largely unchanged for
DM, and increased for RF. The ratio of NT
Indigenous to total Australian mortality
rates increased for all six diseases; this
increase was statistically significant for all
except COPD (Box 4).

* Direct age-standardised and sex-standardised to
◆
the 2001 NT Indigenous population.

4 Estimated annual change in ratio
of Northen Territory Indigenous to
total Australian mortality rates*

Disease

Per cent average
annual change in
ratio (95% CI)

Ischaemic heart disease + 8.1 (7.0 to 9.1)
Chronic obstructive
pulmonary disease

+ 1.2 (0 to 2.4)

Cerebrovascular disease + 4.9 (3.5 to 6.2)
Diabetes mellitus

+ 6.5 (4.8 to 8.2)

Rheumatic heart disease + 6.6 (4.4 to 8.9)

Patterns in mortality trends
The patterns of the different mortality trends
of the six chronic diseases can be used to
generate hypotheses about why these
MJA • Volume 185 Number 3 • 7 August 2006

Renal failure

+ 5.1 (2.7 to 7.6)

* Estimated by negative binomial regression
models.

◆
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changes have occurred. The length of the
intervening period between changes in
determinants and changes in chronic disease
mortality is uncertain, may be quite long,
and is likely to vary between diseases and
between determinants.
Smoking: In the NT, 20% of Aboriginal
adult deaths in 1986–1995 were attributed
to smoking.8 COPD, IHD, lung cancer and
CVD were the four leading causes. We have
shown that COPD peaked in the 1980s and
began to decline in the 1990s. Decreased
smoking was not responsible, as three large
surveys in 1986–1987, 1994 and 2002
showed little change in NT Indigenous
smoking rates.9-11 Other possible reasons for
the decline in COPD deaths include
improved intrauterine growth, fewer childhood infections and less exposure to
tobacco, improved nutrition and less overcrowding decades ago, and, more recently,
better prevention and management of adult
respiratory infections and acute exacerbations of COPD.12
Physical inactivity, poor diet and being
overweight: DM, IHD and CVD are the
chronic diseases most associated with physical inactivity, poor diet and being overweight, and rates of death from IHD and
DM in the NT Indigenous population had
similar upward (although slowing) trajectories, and are the most similar of the six
diseases. There are no long-term NT-wide
trend data available to accurately describe
changes in these behavioural determinants
of disease.
Primary and specialist care: There is some
evidence, at least among people with diabetes, that blood pressure screening and control are routinely occurring in NT
Indigenous bush communities at similar levels to those in the non-Indigenous population.13,14 Reviews of randomised clinical
trials show that blood pressure control leads
to a reduction in mortality from CVD at least
three times greater than that from IHD.15
This may explain the more modest changes
in death rates from CVD than IHD among
NT Indigenous people.
The considerable expansion of primary
care (clinical, disease prevention and health
promotion) services for Indigenous people
in the NT from 1977 to 2001,16,17 combined
with more recent increasing attention to
chronic disease prevention and management,18 may have contributed to improving
control of hypertension over the period.
Hospital care can prevent deaths from
CVD or IHD by improving survival immediately after a stroke or acute myocardial
148

infarction (AMI). Indigenous people experience significant and dangerous delays in
access to NT hospitals after an AMI.19 NT
Indigenous IHD hospital separation rates
increased only slightly faster than IHD
deaths from 1979 to 1991, whereas CVD
hospitalisations nearly trebled when death
rates were stable,20 possibly contributing to
the better CVD than IHD mortality trends.
Birthweight: Low birthweight and poor
infant growth are associated with chronic
disease mortality, although the mechanisms
and public health significance of this association remain contested.21 NT Indigenous
birthweights improved over the study
period,22 but it is not possible to describe
with similar accuracy the birthweight trends
of earlier periods, when those dying of
chronic diseases in 1977–2001 were born.
Underlying social determinants of health:
Accompanying (and often driving) the gradual improvements in access to health care
have been enormous social, economic and
political changes for Indigenous peoples in
the NT since the political struggles of the
1960s. Changing experiences of racism and
social exclusion in parallel with these political changes, together with improvements in
absolute, but not relative, incomes23 and
educational outcomes,24 may have helped
reduce mortality from all diseases.
Conclusion
There is now evidence that the increase in
death rates for all the chronic diseases examined is slowing, or even, as with COPD,
beginning to fall. Some developments (possibly including improving access to medical
care) have been putting the brakes on
increasing chronic disease mortality, but it is
not yet clear whether these positive changes
will eventually lead to a fall in deaths from
all chronic diseases. Now is not the time for
giving up or changing everything because
“nothing has worked”, but for investigating
further what has worked, and for increased
and sustained effort to ensure these early
promises of the possibility of lasting
improvements to Indigenous health are realised in the NT and beyond.
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